本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vogenx

32.50
-1.6300-4.78%
盘后31.51-0.9900-3.05%19:30 EDT
成交量:50.75万
成交额:1,669.58万
市值:4.83亿
市盈率:-287.61
高:38.41
开:34.47
低:31.50
收:34.13
52周最高:38.41
52周最低:12.95
股本:1,485.51万
流通股本:625.00万
量比:3.83
换手率:8.12%
股息:- -
股息率:- -
每股收益(TTM):-0.1130
每股收益(LYR):-0.2652
净资产收益率:--
总资产收益率:--
市净率:-271.25
市盈率(LYR):-122.57

数据加载中...

公司资料

公司名字:
Vogenx
交易所:
NASDAQ
成立时间:
2021
员工人数:
5
公司地址:
3901 Barrett Drive,Suite 300,Raleigh,North Carolina,United States
邮编:
27609
电话:
传真:
- -
简介:
Vogenx, Inc.于2021年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于发现和开发新疗法,用于治疗与人体代谢功能障碍相关的严重疾病,包括减肥后低血糖或PBH,以及胃轻瘫。

董事

名称
职位
James Green
Chairman of the Board and Chief Executive Officer and Director and President
Steven Delmar
Chief Financial Officer and Corporate Secretary and Director
William Wilkison
Chief Scientific Officer and Director
Peter Pieraccini
Director
Richard Gorman
Director
Timothy Boris
Director

股东

名称
职位
James Green
Chairman of the Board and Chief Executive Officer and Director and President
Steven Delmar
Chief Financial Officer and Corporate Secretary and Director
William Wilkison
Chief Scientific Officer and Director